Medicare Advantage


Adjudicating claims for COVID-19 vaccines, their administration and COVID-19 monoclonal antibodies


Beginning January 1, 2022, Medicare Advantage Organizations (MAOs) and Medicare-Medicaid Plans

(MMPs) are responsible for adjudicating claims for COVID-19 vaccines and their administration and for

COVID-19 monoclonal antibodies and their administration. 



Featured In:
December 2021 Anthem Provider News - Georgia